Interestingly, CHEK2 GPV identified in 6/123 (4.9%) early-onset OC patients were significantly associated with earlier age at diagnosis compared to previously analyzed OC patients negative for GPV in HBOP cancer predisposition genes6. This evidence concerns the gene GP5 and cancer.